| Rebekah A Sawyer, | |
|
1501 S Clinton St, Baltimore, MD 21224-5730 | |
| (410) 522-9940 | |
| Not Available |
| Full Name | Rebekah A Sawyer |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology |
| Location | 1501 S Clinton St, Baltimore, Maryland |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356024889 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | R202376 (Maryland) | Primary |
| Entity Name | Baltimore Medical System, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700882503 PECOS PAC ID: 5395653455 Enrollment ID: O20031121000651 |
News Archive
The grim effects that climate change will have on pediatric health outcomes was the focus of a "Viewpoint" article published in the Journal of Clinical Investigation by Susan E. Pacheco, MD, an expert at The University of Texas Health Science Center at Houston.
Forest Laboratories, Inc. and Nycomed today announced that they will present data from six roflumilast posters during the American Thoracic Society (ATS) International Conference being held in New Orleans, LA, May 14 through May 19, 2010. Roflumilast is an investigational anti-inflammatory, oral medication for the treatment of Chronic Obstructive Pulmonary Disease (COPD) associated with chronic bronchitis in patients at risk of exacerbations.
Screening for a panel of gene variants associated with the risk for type 2 diabetes can identify adults at risk for the disorder but is not significantly better than assessment based on traditional risk factors such as weight, blood pressure and blood sugar levels.
The Donald Danforth Plant Science Center announced today that it has received additional funding totaling $11.9 million for the Virus Resistant Cassava for Africa (VIRCA) project to advance its work to improve the health and wellbeing of farmers, their families, and other consumers of cassava living in Sub Saharan Africa.
In her "Global Health Blog," Guardian health editor Sarah Boseley speaks with GlaxoSmithKline CEO Andrew Witty about the year-long efforts to bring together the heads of more than a dozen pharmaceutical companies in a large public-private initiative to control or eliminate neglected tropical diseases.
› Verified 7 days ago
| Entity Name | Johns Hopkins Community Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578598868 PECOS PAC ID: 8325943707 Enrollment ID: O20031220000065 |
News Archive
The grim effects that climate change will have on pediatric health outcomes was the focus of a "Viewpoint" article published in the Journal of Clinical Investigation by Susan E. Pacheco, MD, an expert at The University of Texas Health Science Center at Houston.
Forest Laboratories, Inc. and Nycomed today announced that they will present data from six roflumilast posters during the American Thoracic Society (ATS) International Conference being held in New Orleans, LA, May 14 through May 19, 2010. Roflumilast is an investigational anti-inflammatory, oral medication for the treatment of Chronic Obstructive Pulmonary Disease (COPD) associated with chronic bronchitis in patients at risk of exacerbations.
Screening for a panel of gene variants associated with the risk for type 2 diabetes can identify adults at risk for the disorder but is not significantly better than assessment based on traditional risk factors such as weight, blood pressure and blood sugar levels.
The Donald Danforth Plant Science Center announced today that it has received additional funding totaling $11.9 million for the Virus Resistant Cassava for Africa (VIRCA) project to advance its work to improve the health and wellbeing of farmers, their families, and other consumers of cassava living in Sub Saharan Africa.
In her "Global Health Blog," Guardian health editor Sarah Boseley speaks with GlaxoSmithKline CEO Andrew Witty about the year-long efforts to bring together the heads of more than a dozen pharmaceutical companies in a large public-private initiative to control or eliminate neglected tropical diseases.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rebekah A Sawyer, 1501 S Clinton St Ste 200, Baltimore, MD 21224-5748 Ph: (443) 676-4477 | Rebekah A Sawyer, 1501 S Clinton St, Baltimore, MD 21224-5730 Ph: (410) 522-9940 |
News Archive
The grim effects that climate change will have on pediatric health outcomes was the focus of a "Viewpoint" article published in the Journal of Clinical Investigation by Susan E. Pacheco, MD, an expert at The University of Texas Health Science Center at Houston.
Forest Laboratories, Inc. and Nycomed today announced that they will present data from six roflumilast posters during the American Thoracic Society (ATS) International Conference being held in New Orleans, LA, May 14 through May 19, 2010. Roflumilast is an investigational anti-inflammatory, oral medication for the treatment of Chronic Obstructive Pulmonary Disease (COPD) associated with chronic bronchitis in patients at risk of exacerbations.
Screening for a panel of gene variants associated with the risk for type 2 diabetes can identify adults at risk for the disorder but is not significantly better than assessment based on traditional risk factors such as weight, blood pressure and blood sugar levels.
The Donald Danforth Plant Science Center announced today that it has received additional funding totaling $11.9 million for the Virus Resistant Cassava for Africa (VIRCA) project to advance its work to improve the health and wellbeing of farmers, their families, and other consumers of cassava living in Sub Saharan Africa.
In her "Global Health Blog," Guardian health editor Sarah Boseley speaks with GlaxoSmithKline CEO Andrew Witty about the year-long efforts to bring together the heads of more than a dozen pharmaceutical companies in a large public-private initiative to control or eliminate neglected tropical diseases.
› Verified 7 days ago
Miss Elizabeth Unique Morris, MSN, WHNP-BC Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 330 N Howard St, Baltimore, MD 21201 Phone: 410-576-1414 | |
Christine E. O Connor, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 227 Saint Paul St, 6th Floor, Baltimore, MD 21202 Phone: 410-332-9002 Fax: 410-783-5880 | |
Fateh Hraky Sr., Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3001 S Hanover St, Suite 301, Baltimore, MD 21225 Phone: 410-350-0800 | |
Joyce A Bonsu, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3449 Wilkens Ave Ste 305, Baltimore, MD 21229 Phone: 410-644-2582 Fax: 410-644-6232 | |
Fouad M Abbas, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2411 W Belvedere Ave, Suite 206, Baltimore, MD 21215 Phone: 410-601-9030 | |
Dr. Ginny M Merryman, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6569 N Charles St, Suite 501, Baltimore, MD 21204 Phone: 410-938-8960 Fax: 410-583-9770 | |
Dr. Golsa Mirmiran Yazdy, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4940 Eastern Ave Bldg A1, Baltimore, MD 21224 Phone: 410-550-0337 Fax: 410-550-0196 |